Dual peroxisome proliferator-activated receptor α/δ agonist GFT505 improves hepatic and peripheral insulin sensitivity in abdominally obese subjects (Q34036950)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Dual peroxisome proliferator-activated receptor α/δ agonist GFT505 improves hepatic and peripheral insulin sensitivity in abdominally obese subjects
scientific article

    Statements

    Dual peroxisome proliferator-activated receptor α/δ agonist GFT505 improves hepatic and peripheral insulin sensitivity in abdominally obese subjects (English)
    Bertrand Cariou
    Stéphanie Lambert-Porcheron
    Yassine Zaïr
    Valérie Sauvinet
    Benoit Noël
    Martine Laville
    2923-2930

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit